Drug Profile
Radiolabelled BLyS
Alternative Names: Ardenermin-I-131; Iodine-131 BLyS; Iodine-131 labeled B-Lymphocyte Stimulator; LR131; LymphoRad-131Latest Information Update: 06 Mar 2006
Price :
$50
*
At a glance
- Originator Human Genome Sciences
- Class Antineoplastics; Radiopharmaceuticals
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Multiple myeloma; Non-Hodgkin's lymphoma
Most Recent Events
- 06 Mar 2006 Discontinued - Phase-I for Multiple myeloma in Canada (unspecified route)
- 06 Mar 2006 Discontinued - Phase-I for Multiple myeloma in USA (unspecified route)
- 06 Mar 2006 Discontinued - Phase-I for Non-Hodgkin's lymphoma in Canada (unspecified route)